Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough Laurent GuilleminaultStanislas Grassin-DelyleStuart B. Mazzone Leading Article 21 June 2024
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer’s Disease John A. HeySusan AbushakraMartin Tolar Original Research Article Open access 20 June 2024
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using Quantitative Systems Pharmacology Model John A. HeyJeremy Y. YuMartin Tolar Original Research Article Open access 20 June 2024
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews Giancarlo De la Torre CanalesMariana Barbosa Câmara-SouzaNikolaos Christidis Systematic Review Open access 20 June 2024
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians Sithara RamdasMaryam OskouiLaurent Servais Current Opinion 15 June 2024
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan Carlo LombardiPasquale ComberiatiAlvise Berti Review Article Open access 08 June 2024 Pages: 661 - 684
Therapeutic Potential of Lipoprotein(a) Inhibitors Stephen J. Nicholls Leading Article Open access 08 June 2024 Pages: 637 - 643
Correction: Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain Hannah A. Blair Correction Open access 30 May 2024 Pages: 623 - 623
Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions Cindy-Lee DennisDaisy R. SinglaSimone N. Vigod Review Article 30 May 2024 Pages: 645 - 659
Correction: Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo Connie Kang Correction Open access 29 May 2024 Pages: 745 - 745
Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Ibrahim AkinNazha HamdaniIbrahim El-Battrawy Commentary 29 May 2024 Pages: 703 - 705
Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis Thomas A. AgbaedengJean Jacques NoubiapAzmeraw T. Amare Systematic Review 29 May 2024 Pages: 685 - 701
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned Sarah A. JonesEric F. Morand Leading Article Open access 28 May 2024 Pages: 625 - 635
Ensitrelvir Fumaric Acid: First Approval Yahiya Y. Syed ADISINSIGHT REPORT 25 May 2024 Pages: 721 - 728
Drugs in Development to Treat IgA Nephropathy Lucia Del VecchioMarco AllinoviFrancesco Locatelli Leading Article 23 May 2024 Pages: 503 - 525
Cefepime/Enmetazobactam: First Approval Susan J. Keam ADISINSIGHT REPORT 18 May 2024 Pages: 737 - 744
Correction: Vonoprazan: A Review in Helicobacter pylori Infection Matt Shirley Correction Open access 13 May 2024 Pages: 621 - 621
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments Javier Torres-JiménezJavier Baena EspinarLuis Paz-Ares Correction 13 May 2024 Pages: 619 - 619
Bimekizumab: A Review in Psoriatic Arthritis Tina NieMatt Shirley Adis Drug Evaluation 04 May 2024 Pages: 587 - 598
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease David Valdés-AriasElyana V. T. LocatelliAnat Galor Review Article Open access 23 April 2024 Pages: 549 - 563
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines Congrui ZhuShengmei PangQiangde Duan Review Article 23 April 2024 Pages: 403 - 423
Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis Sarah E. ThomasLiana BarenbrugJuul M. P. A. van den Reek Systematic Review Open access 17 April 2024 Pages: 565 - 578
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders Vito D’AgnanoDomenica Francesca MarinielloFabio Perrotta Leading Article Open access 17 April 2024 Pages: 491 - 501
Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo Connie Kang Adis Drug Evaluation Open access 16 April 2024 Pages: 579 - 586
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments Javier Torres-JiménezJavier Baena EspinarLuis Paz-Ares Review Article 16 April 2024 Pages: 527 - 548
Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain Hannah A. Blair Adis Drug Evaluation Open access 09 April 2024 Pages: 449 - 457
The Pharmacological Landscape for Fatty Change of the Pancreas Maxim S. Petrov Leading Article Open access 04 April 2024 Pages: 375 - 384
Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease Amy Zhuang-YanYahiya Y. Syed Adis Drug Evaluation 30 March 2024 Pages: 441 - 448
Correction: Eplontersen: First Approval Tina Nie Correction Open access 28 March 2024 Pages: 489 - 489
Correction: Zilucoplan: First Approval Matt Shirley Correction Open access 19 March 2024 Pages: 373 - 373
Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1 Connie Kang Correction Open access 15 March 2024 Pages: 371 - 371
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability Alise K. CarlsonMoein AminJeffrey A. Cohen Review Article Open access 14 March 2024 Pages: 285 - 304
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects? Sanne M. BuijsStijn L. W. KoolenAgnes Jager Review Article Open access 14 March 2024 Pages: 385 - 401
Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials Yifan WangHe YiLing Li Systematic Review 13 March 2024 Pages: 425 - 439
Fidanacogene Elaparvovec: First Approval Sohita Dhillon AdisInsight Report 12 March 2024 Pages: 479 - 486
Opioids for Acute Musculoskeletal Pain: A Systematic Review with Meta-Analysis Caitlin M. P. JonesAili LangfordChung-Wei Christine Lin Systematic Review Open access 07 March 2024 Pages: 305 - 317
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection Hannah A. Blair Adis Drug Evaluation 05 March 2024 Pages: 329 - 336
Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options Sara BindoliChiara BaggioPaolo Sfriso Review Article Open access 05 March 2024 Pages: 257 - 274